Sentinel lymph node biopsy is used for
**Core Concept**
Sentinel lymph node biopsy (SLNB) is a diagnostic procedure used to identify the first lymph node that drains a tumor, known as the sentinel lymph node. This technique is employed to assess the spread of cancer to lymph nodes, guiding further treatment decisions.
**Why the Correct Answer is Right**
The sentinel lymph node biopsy is based on the concept of lymphatic drainage, where cancer cells can potentially spread to the nearest lymph node. The procedure involves injecting a radioactive tracer or blue dye near the tumor, which accumulates in the sentinel lymph node. This node is then excised and examined for cancer cells. The accuracy of SLNB relies on the lymphatic drainage patterns of the tumor and the presence of a functional lymphatic system.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as sentinel lymph node biopsy is not primarily used for diagnosing metastatic disease in distant organs.
**Option B:** This option is incorrect as sentinel lymph node biopsy is not a treatment modality but rather a diagnostic tool.
**Option C:** This option is incorrect as sentinel lymph node biopsy is not used to assess the efficacy of neoadjuvant chemotherapy.
**Clinical Pearl / High-Yield Fact**
SLNB is a valuable tool in the management of various cancers, including breast, melanoma, and head and neck cancers. A key consideration in SLNB is the risk of false-negative results, which can occur if the sentinel lymph node is not adequately sampled or if cancer cells have already spread to other lymph nodes.
**Correct Answer: C.**